##################################################################################
# Document Properties Section

SET DOCUMENT Name = "Neuroinflammation"
SET DOCUMENT Description = "BEL File created for Introduction to Systems Biology Modeling Lab course At B-IT University of Bonn"
SET DOCUMENT Version = "1.0"
SET DOCUMENT Copyright = "Copyright (c) 2016, Apurva Gopisetty. All Rights Reserved."
SET DOCUMENT Authors = "Apurva Gopisetty"
SET DOCUMENT Licenses = "CC 3.0"
SET DOCUMENT ContactInfo = "apurva.gopisetty@gmail.com"

##################################################################################
# Definitions Section

# NAMESPACE URLS

DEFINE NAMESPACE ADO AS URL "http://belief.scai.fraunhofer.de/openbel/repository/namespaces/ADO.belns"
DEFINE NAMESPACE AFFX AS URL "http://resource.belframework.org/belframework/20150611/namespace/affy-probeset-ids.belns"
DEFINE NAMESPACE BRCO AS URL "http://belief.scai.fraunhofer.de/openbel/repository/namespaces/BRCO.belns"
DEFINE NAMESPACE CHEBI AS URL "http://resource.belframework.org/belframework/20150611/namespace/chebi.belns"
DEFINE NAMESPACE CHEBIID AS URL "http://resource.belframework.org/belframework/20150611/namespace/chebi-ids.belns"
DEFINE NAMESPACE CHEMBL AS URL "http://belief-demo.scai.fraunhofer.de/openbel/repository/namespaces/chembl-names.belns"
DEFINE NAMESPACE CHEMBLID AS URL "http://belief-demo.scai.fraunhofer.de/openbel/repository/namespaces/chembl-ids.belns"
DEFINE NAMESPACE CTO AS URL "http://belief.scai.fraunhofer.de/openbel/repository/namespaces/CTO.belns"
DEFINE NAMESPACE DO AS URL "http://resource.belframework.org/belframework/20150611/namespace/disease-ontology.belns"
DEFINE NAMESPACE DOID AS URL "http://resource.belframework.org/belframework/20150611/namespace/disease-ontology-ids.belns"
DEFINE NAMESPACE EGID AS URL "http://resource.belframework.org/belframework/20150611/namespace/entrez-gene-ids.belns"
DEFINE NAMESPACE FlyBase AS URL "http://belief.scai.fraunhofer.de/openbel/repository/namespaces/Dmel.belns"
DEFINE NAMESPACE GOBP AS URL "http://resource.belframework.org/belframework/20150611/namespace/go-biological-process.belns"
DEFINE NAMESPACE GOBPID AS URL "http://resource.belframework.org/belframework/20150611/namespace/go-biological-process-ids.belns"
DEFINE NAMESPACE GOCC AS URL "http://resource.belframework.org/belframework/20150611/namespace/go-cellular-component.belns"
DEFINE NAMESPACE GOCCID AS URL "http://resource.belframework.org/belframework/20150611/namespace/go-cellular-component-ids.belns"
DEFINE NAMESPACE HGNC AS URL "http://resource.belframework.org/belframework/20150611/namespace/hgnc-human-genes.belns"
DEFINE NAMESPACE LMSD AS URL "http://belief-demo.scai.fraunhofer.de/openbel/repository/namespaces/LMSD.belns"
DEFINE NAMESPACE MESHC AS URL "http://resource.belframework.org/belframework/20150611/namespace/mesh-chemicals.belns"
DEFINE NAMESPACE MESHCID AS URL "http://resource.belframework.org/belframework/20150611/namespace/mesh-chemicals-ids.belns"
DEFINE NAMESPACE MESHCS AS URL "http://resource.belframework.org/belframework/20150611/namespace/mesh-cellular-structures.belns"
DEFINE NAMESPACE MESHCSID AS URL "http://resource.belframework.org/belframework/20150611/namespace/mesh-cellular-structures-ids.belns"
DEFINE NAMESPACE MESHD AS URL "http://resource.belframework.org/belframework/20150611/namespace/mesh-diseases.belns"
DEFINE NAMESPACE MESHDID AS URL "http://resource.belframework.org/belframework/20150611/namespace/mesh-diseases-ids.belns"
DEFINE NAMESPACE MESHPP AS URL "http://resource.belframework.org/belframework/20150611/namespace/mesh-processes.belns"
DEFINE NAMESPACE MESHPPID AS URL "http://resource.belframework.org/belframework/20150611/namespace/mesh-processes-ids.belns"
DEFINE NAMESPACE MGI AS URL "http://resource.belframework.org/belframework/20150611/namespace/mgi-mouse-genes.belns"
DEFINE NAMESPACE NIFT AS URL "http://belief.scai.fraunhofer.de/openbel/repository/namespaces/NIFT.belns"
DEFINE NAMESPACE NTN AS URL "http://belief.scai.fraunhofer.de/openbel/repository/namespaces/Nutrition.belns"
DEFINE NAMESPACE PDO AS URL "http://belief.scai.fraunhofer.de/openbel/repository/namespaces/PDO.belns"
DEFINE NAMESPACE PH AS URL "http://belief-demo.scai.fraunhofer.de/openbel/repository/namespaces/Placeholder.belns"
DEFINE NAMESPACE PMIBP AS URL "http://belief-demo.scai.fraunhofer.de/BeliefDashboard/dicten/namespaces/pmibp.belns"
DEFINE NAMESPACE PMICHEM AS URL "http://belief-demo.scai.fraunhofer.de/BeliefDashboard/dicten/namespaces/pmichem.belns"
DEFINE NAMESPACE PMICOMP AS URL "http://belief-demo.scai.fraunhofer.de/BeliefDashboard/dicten/namespaces/pmicomp.belns"
DEFINE NAMESPACE PMIDIS AS URL "http://belief-demo.scai.fraunhofer.de/BeliefDashboard/dicten/namespaces/pmidis.belns"
DEFINE NAMESPACE PMIPFAM AS URL "http://belief-demo.scai.fraunhofer.de/BeliefDashboard/dicten/namespaces/pmipfam.belns"
DEFINE NAMESPACE PTS AS URL "http://belief.scai.fraunhofer.de/openbel/repository/namespaces/PTS.belns"
DEFINE NAMESPACE RGD AS URL "http://resource.belframework.org/belframework/20150611/namespace/rgd-rat-genes.belns"
DEFINE NAMESPACE SCHEM AS URL "http://resource.belframework.org/belframework/20150611/namespace/selventa-legacy-chemicals.belns"
DEFINE NAMESPACE SCOMP AS URL "http://resource.belframework.org/belframework/20150611/namespace/selventa-named-complexes.belns"
DEFINE NAMESPACE SDIS AS URL "http://resource.belframework.org/belframework/20150611/namespace/selventa-legacy-diseases.belns"
DEFINE NAMESPACE SFAM AS URL "http://resource.belframework.org/belframework/20150611/namespace/selventa-protein-families.belns"
DEFINE NAMESPACE SP AS URL "http://resource.belframework.org/belframework/20150611/namespace/swissprot.belns"
DEFINE NAMESPACE SPID AS URL "http://resource.belframework.org/belframework/20150611/namespace/swissprot-ids.belns"
DEFINE NAMESPACE dbSNP AS URL "http://belief.scai.fraunhofer.de/openbel/repository/namespaces/SNP.belns"


# ANNOTATION URLS

DEFINE ANNOTATION Anatomy AS URL "http://resource.belframework.org/belframework/20131211/annotation/anatomy.belanno"
DEFINE ANNOTATION BodyRegion AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-body-region.belanno"
DEFINE ANNOTATION CardiovascularSystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-cardiovascular-system.belanno"
DEFINE ANNOTATION Cell AS URL "http://resource.belframework.org/belframework/20131211/annotation/cell.belanno"
DEFINE ANNOTATION CellLine AS URL "http://resource.belframework.org/belframework/20131211/annotation/cell-line.belanno"
DEFINE ANNOTATION CellStructure AS URL "http://resource.belframework.org/belframework/20131211/annotation/cell-structure.belanno"
DEFINE ANNOTATION DigestiveSystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-digestive-system.belanno"
DEFINE ANNOTATION Disease AS URL "http://resource.belframework.org/belframework/20131211/annotation/disease.belanno"
DEFINE ANNOTATION FluidAndSecretion AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-fluid-and-secretion.belanno"
DEFINE ANNOTATION HemicAndImmuneSystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-hemic-and-immune-system.belanno"
DEFINE ANNOTATION IntegumentarySystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-integumentary-system.belanno"
DEFINE ANNOTATION MeSHAnatomy AS URL "http://resource.belframework.org/belframework/20131211/annotation/mesh-anatomy.belanno"
DEFINE ANNOTATION MeSHDisease AS URL "http://resource.belframework.org/belframework/20131211/annotation/mesh-diseases.belanno"
DEFINE ANNOTATION NervousSystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-nervous-system.belanno"
DEFINE ANNOTATION RespiratorySystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-respiratory-system.belanno"
DEFINE ANNOTATION Species AS URL "http://resource.belframework.org/belframework/20131211/annotation/species-taxonomy-id.belanno"
DEFINE ANNOTATION Tissue AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-tissue.belanno"
DEFINE ANNOTATION UrogenitalSystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-urogenital-system.belanno"

##################################################################################
# Statements Section

SET STATEMENT_GROUP = "Group 1"

# Add statements below this comment
# Citation = {"SOURCE", "Publication info", "PUBMED ID"}

############## 19668193 ################
SET Citation = {"PubMed","Nat Med. 2009 Sep;15(9):1038-45. doi: 10.1038/nm.2003. Epub 2009 Aug 9.","19668193"}

SET Evidence = "Arising from CD19+ B cells, GIFT15 B(reg) cells express major histocompatibility complex class I (MHCI) and MHCII, 
surface IgM and IgD, and secrete IL-10, akin to previously described B10 and T2-MZP B(reg) cells, but lose expression of the transcription 
factor PAX5, coupled to upregulation of CD138 and reciprocal suppression of CD19."
sec(p(HGNC:IL10)) -- complex(SCOMP:"MHC Class I Complex")
p(RGD:Igh-6) -- complex(SCOMP:"MHC Class I Complex")
p(HGNC:IL10) -- p(RGD:Igh-6)
p(HGNC:CD19) -- p(HGNC:IL10)
p(HGNC:SDC1) -- p(HGNC:PAX5)


###################### 19748567 #######################################

SET Citation = {"PubMed", "Brain Behav Immun. 2010 Jan;24(1):119-26. doi: 10.1016/j.bbi.2009.09.002. Epub 2009 Sep 11.","19748567"}

SET Evidence = "The results demonstrate that the GFAP-IL6 mice are resistant to high-fat 
diet-induced increases in body weight and body fat, apparently without altering food intake 
and with no evidences of increased sympathetic tone. "

p(MGI:Il6) -> a(MESHPP:"Body Mass Index")
p(HGNC:IL6) -- p(HGNC:GFAP)

SET Evidence = "The high-fat diet-induced impaired responses to an insulin tolerance test (ITT), 
and to an oral glucose tolerance test (OGTT) in both genotypes."
a(MESHPP:"Body Mass Index") -| p(HGNC:INS)

##################### 19800321 #########################

SET Citation = {"PubMed","Biochem Pharmacol. 2010 Feb 15;79(4):596-609. doi: 10.1016/j.bcp.2009.09.026.","19800321"}

SET Evidence = " From the mouse microglia cell-based assays, an imidazo [4,5-b] pyridine compound KR-31360 
was identified as an inhibitor of microglial NO production with an IC(50) value of 2 microM."
SET Species = "10090"
SET Cell = "microglial cell"
p(CHEBI:"pyridine") -| a(CHEBI:"nitric oxide")


SET Evidence = "KR-31360 also inhibited lipopolysaccharide (LPS)-induced secretion of tumor necrosis factor alpha 
(TNF-alpha) and transcription of TNF-alpha, interleukin-1 beta, and inducible nitric oxide synthase as well as activation of 
nuclear factor kappa B and mitogen-activated protein kinases."
p(CHEBI:"3-[(2-methoxyphenyl)methyl]imidazo[4,5-b]pyridine") -| r(HGNC:IL1A)
p(CHEBI:"3-[(2-methoxyphenyl)methyl]imidazo[4,5-b]pyridine") -| r(HGNC:TNF)
p(CHEBI:"3-[(2-methoxyphenyl)methyl]imidazo[4,5-b]pyridine") -| sec(p(HGNC:TNF))
p(CHEBI:"3-[(2-methoxyphenyl)methyl]imidazo[4,5-b]pyridine") -| p(HGNC:NFKB)
p(CHEBI:"3-[(2-methoxyphenyl)methyl]imidazo[4,5-b]pyridine") -| bp(GOBP:"MAPK cascade")


############################ 19853010 #####################

SET Citation = {"PubMed","Prog Neurobiol. 2010 Feb 9;90(2):256-62. doi: 10.1016/j.pneurobio.2009.10.015. Epub 2009 Oct 21.","19853010"}

SET Evidence = "In the brain, the constitutive expression is low, but activated microglia produce and release interleukin-1 during 
pathological conditions such as neurodegenerative disorders (e.g. stroke, 
traumatic brain injury, Alzheimer's disease, Parkinson's disease)."
SET MeSHAnatomy = "brain"
path(MESHD:"Neurodegenerative Diseases") -> p(HGNC:IL1B)

SET Evidence = "Interleukin-1 has an important role in mediating 'sickness symptoms' such as fever, in response to infections."
path(MESHD:Infection) -- p(HGNC:IL1B)  
path(MESHD:Fever) -- p(HGNC:IL1B)

SET Evidence = "Moreover, deregulated expression of interleukin-1 is associated with ageing-related chronic neurodegenerative disorders."
path(MESHD:"Neurodegenerative Diseases") -- p(HGNC:IL1B)


########################### 19881300 #######################

SET Citation = {"PubMed","Biol Pharm Bull. 2009 Nov;32(11):1870-4.","19881300"}

SET Evidence = "A viral component (double-stranded (ds)RNA) triggers a toll-like receptor 3-dependent inflammatory response 
that stimulates pro-inflammatory mediators in the brain."
a(SCHEM:"double-stranded RNA") -- p(HGNC:TLR3)
p(HGNC:TLR3) -- bp(GOBP:"inflammatory response")

SET Evidence = "Both compounds inhibited dsRNA-induced inducible nitric oxide synthase (iNOS) expression, a major pro-inflammatory enzyme."
a(MESHC:fraxinellone) -| r(HGNC:NOS2)
a(MESHC:sauchinone)-| r(HGNC:NOS2)

SET Evidence = "Our data show that dsRNA promotes the expression of signal transducers and activators of transcription (STAT)1/3 identified 
as major inflammatory transcription factors as well as activates c-Jun N-terminal kinase (JNK) in an early time."
a(SCHEM:"double-stranded RNA") -> p(HGNC:MAPK8)

SET Evidence = "These results suggest that an anti-inflammatory effect by fraxinellone and sauchinone is mediated via blockade of the 
JNK-STAT1/3-iNOS signaling pathway in viral-infected microglia."
p(HGNC:NOS2) -- p(HGNC:MAPK8)


############################ 20038643 ##########################

SET Citation = {"PubMed","J Immunol. 2010 Feb 1;184(3):1499-506. doi: 10.4049/jimmunol.0903302. Epub 2009 Dec 28.","20038643"}

SET Evidence = "Sema4D/CD100, a class IV semaphorin, has been shown to be involved in the 
nervous and immune systems through its receptors plexin-B1 and CD72, respectively."
p(HGNC:SEMA4D) -- bp(GOBP:"central nervous system")
p(HGNC:SEMA4D) -- bp(GOBP:"immune system process")

SET Evidence = "We found that Sema4D promoted inducible NO synthase expression by primary mouse 
microglia, the effects of which were abolished in plexin-B1-deficient but not in CD72-deficient microglia."
SET Cell = "microglial cell"
p(HGNC:SEMA4D) -> r(HGNC:NOS2)
p(HGNC:PLXNB1) -| p(HGNC:NOS2)
UNSET Cell

SET Evidence = "In addition, during the development of experimental autoimmune encephalomyelitis (EAE), which was induced by immunization with 
myelin oligodendrocyte glycoprotein-derived peptides, we observed that the expression of Sema4D and plexin-B1 
was induced in infiltrating mononuclear cells and microglia, respectively."
p(HGNC:PLXNB1) -- path(MESHD:Encephalomyelitis)
p(HGNC:SEMA4D) -- path(MESHD:Encephalomyelitis)

SET Evidence = "Collectively, our findings demonstrate the role of Sema4D-plexin-B1 interactions in the activation of 
microglia and provide their pathologic significance in neuroinflammation."

complex(p(HGNC:SEMA4D),p(HGNC:PLXNB1)) -- path(MESHD:"Neuroinflammation")


############################ 20064570 ##############################

SET Citation = {"PubMed","Neurochem Int. 2010 Mar;56(4):585-9. doi: 10.1016/j.neuint.2009.12.022. Epub 2010 Jan 12.","20064570"}

SET Evidence = "Neuroinflammation is believed to play an important role in neurological diseases such as Alzheimer's disease (AD)."
path(MESHD:"Neuroinflammation")-- path(MESHD:"Alzheimer Disease")
path(MESHD:"Alzheimer Disease") -- path(MESHD:"Nervous System Diseases")

SET Evidence =  "Growing evidence suggests that n-3 PUFA have protective effects by inhibiting inflammatory 
processes including synthesis of eicosanoids from arachidonic acid."
a(CHEBI:"polyunsaturated fatty acid") -| a(CHEBI:icosanoid)
a(SCHEM:"Arachidonic acid") -- a(CHEBI:icosanoid)

SET Evidence = "Therefore, in this study, the effect of n-3 PUFA on brain cortex fatty acid composition, and on the 
expression of calcium-dependant cytosolic phospholipase A(2) (cPLA(2)) 
and cyclooxygenase-2 (COX-2) was assessed in the transgenic fat-1 mouse."
a(SCHEM:Calcium) -> p(HGNC:PLA2G4A)
a(CHEBI:"polyunsaturated fatty acid") -- r(HGNC:PLA2G4A)


################################ 20162721 #################################

SET Citation = {"PubMed","J Neurosci Res. 2010 Aug 1;88(10):2188-96. doi: 10.1002/jnr.22378.","20162721"}

SET Evidence = "Glucocorticoid-induced tumor necrosis factor receptor family-related protein ligand (GITRL) is 
a member of the tumor necrosis factor superfamily (TNFSF) and is known to act as a costimulator in the immune system 
by binding to GITR."
p(HGNC:TNFSF18) -- bp(GOBP:"immune system process")

SET Evidence = "stimulation of GITRL induces inflammatory activation of microglia on the basis of production of nitric oxide (NO)
and expression of inducible nitric oxide synthase"
p(HGNC:TNFSF18) -> a(CHEBI:"nitric oxide")

SET Evidence = " GITRL stimulation also induces microglia cell death."
SET Cell = "microglial cell"
p(HGNC:TNFSF18) -> bp(GOBP:"cell death")

SET Evidence = "GITRL-mediated microglial NO production partially depends on p38 MAPK, JNK, and nuclear factor-kappaB pathways"
a(CHEBI:"nitric oxide") -- p(HGNC:MAPK14) 
p(HGNC:MAPK14) -- p(HGNC:NFKB)
UNSET Cell

################################# 20385796 ###############################

SET Citation = {"PubMed","Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7969-74. doi: 10.1073/pnas.1001056107. Epub 2010 Apr 12.","20385796"}

SET Evidence = "    Familial Danish dementia (FDD) is a progressive neurodegenerative disease with cerebral 
deposition of Dan-amyloid (ADan), neuroinflammation, and neurofibrillary tangles, 
hallmark characteristics remarkably similar to those in Alzheimer's disease (AD)"
path(MESHD:"Neurodegenerative Diseases") -- path(ADO:"Neurofibrillary_tangle")
path(MESHD:"Neurodegenerative Diseases") -- path(MESHD:"Neuroinflammation")
path(MESHD:"Neurodegenerative Diseases") -- path(MESHD:"Alzheimer Disease")


################################### 20404154 ########################

SET Citation = {"PubMed","Proc Natl Acad Sci U S A. 2010 May 4;107(18):8416-21. doi: 10.1073/pnas.0910627107. Epub 2010 Apr 19.","20404154"}

SET Evidence = "Astroglial reactivity associated with increased production of NFkappaB-dependent proinflammatory molecules is an important component of 
the pathophysiology of chronic neurological disorders such as multiple sclerosis (MS)."
path(MESHD:"Multiple Sclerosis") -- p(HGNC:NFKB1)
path(MESHD:"Nervous System Diseases") -- p(HGNC:NFKB1)
path(MESHD:"Multiple Sclerosis") -- path(MESHD:"Nervous System Diseases")

SET Evidence = "Using mouse experimental allergic encephalomyelitis (EAE) as a model of chronic neuroinflammation, we report that implants reproducing pregnancy levels of 
17beta-estradiol (E2) alleviate ongoing disease and decrease astrocytic production of CCL2, 
a proinflammatory chemokine that drives the local recruitment of inflammatory myeloid cells."
a(SCHEM:chemokine) -- a(CHEMBLID:CHEMBL49440)
a(SCHEM:chemokine) -- p(HGNC:CCL2)

SET Evidence = "In cultured rodent astrocytes, E2 or an ERalpha agonist, but not an ERbeta agonist, inhibits TNFalpha-induced CCL2 expression at 
nanomolar concentrations, and the ER antagonist ICI 182,170 blocks this effect."
SET Cell="Astrocytes"
p(HGNC:CCL2) -- p(HGNC:TNF)

SET Evidence = "Chromatin immunoprecipitation assays further indicate that estrogen suppresses 
TNFalpha-induced NFkappaB recruitment to the CCL2 enhancer."
a(CHEBI:estrogen) -| p(HGNC:NFKB1)
p(HGNC:NFKB1) -| p(HGNC:CCL2)

################################ 20557428########################

SET Citation = {"PubMed","J Neurochem. 2010 Sep 1;114(5):1511-26. doi: 10.1111/j.1471-4159.2010.06867.x. Epub 2010 Jun 16.","20557428"}

SET Evidence = "As the transcriptional activator retinoic acid (RA), used for chemotherapy and dermatological applications, exerts anti-inflammatory effects on monocytes and lymphocytes, 
we have tested whether the physiologically occurring isomer, all-trans RA, affects chemokine expression by astrocytes."
a(CHEBI:"all-trans-retinoic acid") -- a(SCHEM:"chemokine")
a(CHEBI:lipopolysaccharide) -> path(MESHD:"Inflammation")
a(CHEBI:lipopolysaccharide) -> p(HGNC:CCL2)
a(CHEBI:lipopolysaccharide) -> p(HGNC:CCL3)
a(CHEBI:lipopolysaccharide) -> p(HGNC:CCL5)
a(CHEBI:lipopolysaccharide) -> p(HGNC:CCL1)
a(CHEBI:lipopolysaccharide) -> p(HGNC:CXCL2)

SET Evidence = "    The anti-inflammatory activity of RA engaged RA and retinoid X receptors and correlated with a 
decreased expression of the lipopolysaccharides co-receptor CD14."
complex(a(CHEBI:"all-trans-retinoic acid"),p(SFAM:"RXR Family")) -| a(CHEBI:lipopolysaccharide)
p(HGNC:CD14) -- a(CHEBI:lipopolysaccharide)
 
SET Evidence = "A minor reduction of nuclear NF-kappaB was observed but not significant, activation of Jun amino-terminal kinase, 
p38 and signal transducer and activator of transcription 3 were not altered by RA."
complex(a(CHEBI:"all-trans-retinoic acid"),p(SFAM:"RXR Family")) -| a(CHEBI:lipopolysaccharide)
p(HGNC:CD14) -- a(CHEBI:lipopolysaccharide)
a(CHEBI:lipopolysaccharide) -| p(HGNC:NFKB1)

########################## 20566832 ###########################

SET Citation = {"PubMed","J Immunol. 2010 Jul 15;185(2):1230-7. doi: 10.4049/jimmunol.1000208. Epub 2010 Jun 21.","20566832"}

SET Evidence = "MPTP induced degeneration of nigrostriatal DA neurons and glial activation as visualized by tyrosine hydroxylase, 
macrophage Ag complex-1, and/or glial fibrillary acidic protein immunoreactivity."
p(HGNC:GFAP) -- a(CHEMBLID:CHEMBL24172)
p(HGNC:TH) -- a(CHEMBLID:CHEMBL24172)

SET Evidence = "Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and 
oxidative stress in an experimental model of Parkinson's disease."
a(CHEBI: "paroxetine") -| path(MESHD:Encephalitis)
a(CHEBI: "paroxetine") -| a(SCHEM:"Reactive Oxygen Species")


######################### 20631174 ##################################

SET Citation = {"PubMed","J Neurosci. 2010 Jul 14;30(28):9454-64. doi: 10.1523/JNEUROSCI.5796-09.2010.","20631174"}

SET Evidence = "We now show that CD40, a receptor for CD40L, is highly expressed in brain endothelial cells of 
patients affected by HIV-1 encephalitis (HIVE), suggesting an important role for the 
CD40/CD40L dyad in regulating blood-brain barrier (BBB) functions."
SET Cell = "endothelial cell"
SET NervousSystem = "Brain"
p(HGNC:CD40LG) -- p(HGNC:CD40)
path(MESHD:Encephalitis)-> p(HGNC:CD40)
path(MESHD:Encephalitis) -- bp(GOBP:"maintenance of blood-brain barrier")
UNSET NervousSystem
UNSET Cell

SET Evidence = "CD40L induced activation of mixed-lineage-kinase-3 and JNK, leading to the 
subsequent activation of cJUN/AP-1 (activating-protein-1)."
p(HGNC:CD40LG) -> p(HGNC:MAP3K11)
p(HGNC:MAP3K11) -> p(HGNC:MAPK8)
p(HGNC:MAP3K11) -> p(HGNC:JUN)


########################## 20637688 ######################3

SET Citation = {"PubMed","J Clin Virol. 2010 Sep;49(1):4-10. doi: 10.1016/j.jcv.2010.06.009. Epub 2010 Jul 15.","20637688"}

SET Evidence = "Histopathology of brain was done to observe the morphological changes after JEV infection and genes relevant to 
macrophage activation, chemokine secretion, inflammatory cell infiltration, and blood-brain barrier permeability were examined at their 
gene and protein expression level for various time points after infection."

sec(a(SCHEM:chemokine))-- sec(bp(GOBP:"macrophage activation"))


########################## 20657581 #############################

SET Citation = {"PubMed","Nat Med. 2010 Aug;16(8):897-902. doi: 10.1038/nm.2183. Epub 2010 Jul 25.","20657581"}

SET Evidence = "High amounts of glutamate are found in the brains of people with multiple sclerosis, an inflammatory 
disease marked by progressive demyelination."
SET NervousSystem = "Brain"
a(SCHEM:"L-Glutamate") -- path(MESHD:"Multiple Sclerosis")

SET Evidence = "In dendritic cells (DCs) from those mice, defective mGluR4 signaling-which would normally decrease intracellular 
cAMP formation-biased T(H) cell commitment to the T(H)17 phenotype."
a(SCHEM:"cyclic AMP") -- p(HGNC:GRM4)


######################## 20689579 ############################

SET Citation = {"PubMed","PLoS One. 2010 Jul 30;5(7):e11866. doi: 10.1371/journal.pone.0011866.","20689579"}

SET Evidence = " Amyloid precursor protein (APP) occupies a central position in AD and APP-derived amyloid-beta (Abeta) peptides 
are thought to play a pivotal role in disease pathogenesis."
path(MESHD:"Alzheimer Disease") -- p(HGNC:APP)

SET Evidence = "APP intracellular domain (AICD) is generated together with Abeta and we recently showed that AICD transgenic mice 
recapitulate pathological features of AD such as tau hyperphosphorylation, memory 
deficits and neurodegeneration without increasing the Abeta levels."
SET Species = "10090"
p(HGNC:APP) -- bp(SDIS:"Neurodegeneration")


####################### 20696240 ###############################

SET Citation = {"PubMed","Biochim Biophys Acta. 2011 Feb;1812(2):162-76. doi: 10.1016/j.bbadis.2010.07.016. Epub 2010 Aug 6.","20696240"}

SET Evidence = " The HERV-W family has received substantial attention in large part because of associations with diverse syndromes including 
multiple sclerosis (MS) and several psychiatric disorders."
p(HGNC:"endogenous retrovirus group W member 1") -- path(MESHD:"Multiple Sclerosis")

SET Evidence = ". A HERV-W-related retroelement, multiple sclerosis retrovirus (MSRV), has been reported in 
MS patients to be both a biomarker as well as an effector of aberrant immune responses."
p(HGNC:"endogenous retrovirus group W member 1") biomarkerFor bp(GOBP:"immune response")

############################################################################33
###############END OF ANNOTATION ###########################


UNSET STATEMENT_GROUP

